TNXP
TonixFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
Current thesis
Composite grade F from latest DB weights. Momentum 10.4 / Value 58.8
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +17.7.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
10
Value
59
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $44.25
Why
Momentum10 · Δ7d +1.8
Value59 · Δ7d +17.7
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
10
40% active weight
Current posture
7d trendSoftening
Δ7d
+1.8
Δ21d
+6.1
Value
59
60% active weight
Current posture
7d trendImproving
Δ7d
+17.7
Δ21d
+17.6
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 10.4 / Value 58.8
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$175.03M
Beta
1.90
Shares Out
15.94M
P/E (TTM) · Derived
-0.8
P/S (TTM)
18.90
P/FCF (TTM) · Derived
-0.87
Rev YoY
+183.2%
EPS YoY
+3.3%
Gross Margin
+47.2%
Op Margin
-990.3%
Net Debt
-$206.33M
Current Ratio
6.99
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology